U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Safety
  3. Recalls, Market Withdrawals, & Safety Alerts
  4. WS Global Issues Nationwide Recall of Himalayan Pain Relief Tea Due to the Presence of Hidden Drug Ingredients, Diclofenac and Dexamethasone
  1. Recalls, Market Withdrawals, & Safety Alerts

COMPANY ANNOUNCEMENT

WS Global Issues Nationwide Recall of Himalayan Pain Relief Tea Due to the Presence of Hidden Drug Ingredients, Diclofenac and Dexamethasone

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement

Summary

Company Announcement Date:
FDA Publish Date:
Product Type:
Food & Beverages
Coffee/Tea
Reason for Announcement:
Recall Reason Description
Undeclared drugs, Diclofenac and Dexamethasone
Company Name:
WS Global, Inc.
Brand Name:
Brand Name(s)
Himalayan
Product Description:
Product Description
Tea

Company Announcement

FOR IMMEDIATE RELEASE – Date: 12/13/2023 –WS Global, INC Brooklyn, NY is voluntarily recalling all lots of Himalayan Pain Relief Tea, tea packets to the consumer level. The products have been found to contain undeclared drugs, Diclofenac and Dexamethasone.

Diclofenac is a non-steroidal anti-inflammatory drug (commonly referred to as NSAIDs). NSAIDs may cause increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration, and fatal perforation of the stomach and intestines. This hidden drug ingredient may also interact with other medications and significantly increase the risk of adverse events, particularly when consumers use multiple NSAID-containing products.

Dexamethasone is a corticosteroid commonly used to treat inflammatory conditions. Corticosteroid use can impair a person’s ability to fight infections and can cause high blood sugar levels, muscle injuries and psychiatric problems. When corticosteroids are taken for a prolonged period, or at high doses, they can suppress the adrenal gland. Only licensed health care professionals can evaluate patients for the risk or existence of adrenal suppression. In addition, the undeclared dexamethasone in Himalayan Pain Relief Tea may cause serious side effects when combined with other medications.

Product was distributed Nationwide through Amazon (internet) and online only.

The product is used as tea and is packaged in a light-yellow box containing 6 tea packets, printed with barcode 0841920015. The affected Himalayan Pain Relief Tea lots include the following “ALL LOTS”.

To date WS Global Inc., has not received any reports of adverse events related to this recall.

Consumers taking Himalayan Pain Relief Tea should immediately consult their health care professional to safely discontinue use of this product. The risks of withdrawal from corticosteroids should be assessed by a health care professional. Abrupt discontinuation can cause withdrawal symptoms.

Consumers with questions regarding this recall can contact WSGLOBAL INC by email wsnyinc@outlook.com, we’ll respond within 12-24 business hours and welcome to call or text us at 347-925-1755.            

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online
  • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Company Contact Information

Consumers:
WSGLOBAL INC
347-925-1755
wsnyinc@outlook.com
Media:
Matt Ouyang
347-925-1755
Back to Top